Skip to main contentAll experts

Nicole Smolinski

RES AST PROF

PH-PHARM OUTCOMES & POLICY

  • RES AST PROF
    PH-PHARM OUTCOMES & POLICY

GRANTS

  • GRANT
    A Post-Marketing Study to Evaluate the Safety of ABRYSVO™ on the Risk of Guillain-Barré Syndrome (GBS) in Pregnancy
    Pfizer Inc3 Mar 2025 - 30 Jun 2026
    Expired
  • GRANT
    Surveillance of Muscular Dystrophies
    Centers for Disease Control and Prevention5 Aug 2024 - 31 Aug 2028
    Active